We are a committed team of visionary founders and experienced advisors supporting the mission of bringing our superior computer-based assessment tool to the clinical market.
Brainreader has developed a cost-effective and easy to use technology that can analyse MRI images. The Neuroreader™ software enables accurate measures of specific brain structures giving the physician a more objective data when working with atrophy in brain structures in e.g. early stages of Alzheimer´s disease.
The standardized and automated features of Neuroreader™ assists the clinicians in assessing brain atrophy correctly. This brings objectivity and confident into the clinical work-flow. Press this link to test Neuroreader at your clinic today.
03.07.2014 – Brainreader is proud to announce that the quality system of the company fulfills the requirements in EN ISO 13485:2012 and ISO 13485:2003 and therefore has been certified today.
It is our vision that ultimately Brainreader will enable more precise and efficient treatment of neuro-degenerative diseases through objective, precise, and personal analysis of brain scans. Allowing increased quality of life for the patient and significantly reducing disease-related costs for society.